NASDAQ / LIVE COMPANY INTELLIGENCE

ANI Pharmaceuticals, Inc.

Nasdaq-listed company. Follow earnings, filings, products, capital and the competitive forces moving the company.

TICKERANIP
CORENasdaq-listed company
WATCHEarnings + filings + operating news
STATUSContinuously updated
LIVE / ANIP COVERAGE

What’s moving ANI Pharmaceuticals, Inc. now

Current reporting with the operating signal separated from the noise.

01
ANI Pharmaceuticals, Inc. (ANIP) Q4 2025 Earnings Call Transcript

ANI Pharmaceuticals, Inc. (ANIP) Q4 2025 Earnings Call Transcript

Investors are testing whether ANI Pharmaceuticals, Inc.’s operating performance supports its strategy and valuation.

Watch next: the filing, cash flow, guidance and capital-expenditure plan.
02
ANI Pharmaceuticals, Inc. (ANIP) Hits Milestone with Cortrophin Gel Prefilled Syringe Launch

ANI Pharmaceuticals, Inc. (ANIP) Hits Milestone with Cortrophin Gel Prefilled Syringe Launch

The development tests whether ANI Pharmaceuticals, Inc. can turn product investment into adoption, revenue and durable advantage.

Watch next: confirmation in a company filing, official release or regulator record.
03
ANI Pharmaceuticals, Inc. to Release Fourth Quarter and Full Year 2024 Financial Results on February 28, 2025

ANI Pharmaceuticals, Inc. to Release Fourth Quarter and Full Year 2024 Financial Results on February 28, 2025

The story matters when it changes ANI Pharmaceuticals, Inc.’s customers, execution, competitive position or capital requirements.

Watch next: confirmation in a company filing, official release or regulator record.
04
ANI Pharmaceuticals, Inc. Prices Upsized $275.0 Million Convertible Senior Notes Offering

ANI Pharmaceuticals, Inc. Prices Upsized $275.0 Million Convertible Senior Notes Offering

The story matters when it changes ANI Pharmaceuticals, Inc.’s customers, execution, competitive position or capital requirements.

Watch next: confirmation in a company filing, official release or regulator record.
05
ANI Pharmaceuticals, Inc. (ANIP) Q1 2024 Earnings Call Transcript

ANI Pharmaceuticals, Inc. (ANIP) Q1 2024 Earnings Call Transcript

Investors are testing whether ANI Pharmaceuticals, Inc.’s operating performance supports its strategy and valuation.

Watch next: the filing, cash flow, guidance and capital-expenditure plan.
PRIMARY DOCUMENTS / SEC EDGAR

Latest ANIP filings.

Investor-relevant reports are shown first, followed by the company’s other recent official submissions.

10-QQuarterly financial reportFiled 2026-05-08 · Period 2026-03-31SEC ↗10-QQuarterly financial reportFiled 2025-11-07 · Period 2025-09-30SEC ↗10-KAnnual financial reportFiled 2026-02-27 · Period 2025-12-31SEC ↗8-KMaterial company eventFiled 2026-05-21 · Period 2026-05-21SEC ↗8-KMaterial company eventFiled 2026-05-13 · Period 2026-05-13SEC ↗8-KMaterial company eventFiled 2026-05-08 · Period 2026-05-08SEC ↗DEF 14AProxy and shareholder meetingFiled 2026-04-09 · Period 2025-12-31SEC ↗4Official SEC filingFiled 2026-07-30 · Period 2026-07-29SEC ↗
EARNINGS / QUARTERLY TRACKER

ANI Pharmaceuticals, Inc., quarter by quarter.

Results, guidance and earnings coverage are grouped only when the source headline identifies the reporting period.